Iron levels in polarized macrophages: Regulation of immunity and autoimmunity

Autoimmunity Reviews

Volumn 11, Issue 12, 2012, Pages 883-889

  Recalcati, Stefania ^a   Locati, Massimo ^a,b   Gammella, Elena ^a   Invernizzi, Pietro ^b   Cairo, Gaetano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Anemia of chronic disease; Ferroportin; Inflammation; Innate immunity; Iron; Polarized macrophages

Indexed keywords

DEFEROXAMINE; HEPCIDIN; IRON;

ANEMIA; ANEMIA OF CHRONIC DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIOSTASIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL HETEROGENEITY; CHRONIC INFLAMMATION; CIRCULATION; IMMUNOREGULATION; IRON METABOLISM; MACROPHAGE; PATHOGENESIS; PHENOTYPE; POLARIZATION; REVIEW; RHEUMATOID ARTHRITIS; TUMOR GROWTH;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOMODULATION; INFLAMMATION MEDIATORS; IRON; MACROPHAGE ACTIVATION; MACROPHAGES;

EID: 84866531103     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.03.003     Document Type: Review

References (79)

1. Bach J.F. Infections and autoimmune diseases. J Autoimmun 2005, 25:74-80.
2. Youinou P., Pers J.O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010, 34:J163-J167.
3. Tomer Y., Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009, 32:231-239.
4. Sousa G.M., Oliveira R.C., Pereira M.M., Parana R., Sousa-Atta M.L., Atta A.M. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev 2011, 10:210-213.
5. Behrens M., Smart M., Luckey D., Luthra H., Taneja V. To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 2011, 37:95-103.
6. Fu S.M., Deshmukh U.S., Gaskin F. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 2011, 37:104-112.
7. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2011, 35:219-224.
8. Longhi M.S., Ma Y., Mieli-Vergani G., Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2011, 34:7-14.
9. Jager N.A., Teteloshvili N., Zeebregts C.J., Westra J., Bijl M. Macrophage folate receptor-beta (FR-beta) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?. Autoimmun Rev Nov 7 2011, [Epub ahead of print].
10. Orme J., Mohan C. Macrophages and neutrophils in SLE-an online molecular catalog. Autoimmun Rev 2012, 11:365-372.
11. Lin Y.T., Wang C.T., Gershwin M.E., Chiang B.L. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 2011, 10:482-489.
12. Munoz L.E., Janko C., Schulze C., Schorn C., Sarter K., Schett G., et al. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 2010, 10:38-42.
13. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
14. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
15. Cutolo M., Montagna P., Brizzolara R., Sulli A., Seriolo B., Villaggio B., et al. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients. J Autoimmun 2009, 32:254-260.
16. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262.
17. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
18. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
19. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
20. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-7311.
21. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
22. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
23. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 10:1033-1043.
24. Moura E., Noordermeer M.A., Verhoeven N., Verheul A.F., Marx J.J. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 1998, 92:2511-2519.
25. Andrews N.C. The iron transporter DMT1. Int J Biochem Cell Biol 1999, 31:991-994.
26. Recalcati S., Pometta R., Levi S., Conte D., Cairo G. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood 1998, 91:2565-2572.
27. Recalcati S., Taramelli D., Conte D., Cairo G. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 1998, 91:1059-1066.
28. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516.
29. Recalcati S., Invernizzi P., Arosio P., Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 2008, 30:84-89.
30. Ludwiczek S., Aigner E., Theurl I., Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003, 101:4148-4154.
31. Recalcati S., Locati M., Marini A., Santambrogio P., Zaninotto F., De Pizzol M., et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol 2010, 40:824-835.
32. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005, 1:191-200.
33. Abboud S., Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000, 275:19906-19912.
34. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000, 5:299-309.
35. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000, 403:776-781.
36. Yang F., Liu X.B., Quinones M., Melby P.C., Ghio A., Haile D.J. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 2002, 277:39786-39791.
37. Peyssonnaux C., Zinkernagel A.S., Datta V., Lauth X., Johnson R.S., Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 2006, 107:3727-3732.
38. Wallander M.L., Leibold E.A., Eisenstein R.S. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta 2006, 1763:668-689.
39. Andrews N.C. Forging a field: the golden age of iron biology. Blood 2008, 112:219-230.
40. Robach P., Recalcati S., Girelli D., Gelfi C., Aachmann-Andersen N.J., Thomsen J.J., et al. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin. Blood 2009, 113:6707-6715.
41. Muckenthaler M.U. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 2008, 8:1-3.
42. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010, 142:24-38.
43. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 2006, 107:328-333.
44. Nguyen N.B., Callaghan K.D., Ghio A.J., Haile D.J., Yang F. Hepcidin expression and iron transport in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2006, 291:L417-L425.
45. Theurl I., Theurl M., Seifert M., Mair S., Nairz M., Rumpold H., et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 2008, 111:2392-2399.
46. Sindrilaru A., Peters T., Wieschalka S., Baican C., Baican A., Peter H., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011, 121:985-997.
47. Wang L., Harrington L., Trebicka E., Shi H.N., Kagan J.C., Hong C.C., et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest 2009, 119:3322-3328.
48. Zhang Z., Zhang F., An P., Guo X., Shen Y., Tao Y., et al. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 2011, 118:1912-1922.
49. She H., Xiong S., Lin M., Zandi E., Giulivi C., Tsukamoto H. Iron activates NF-kappaB in Kupffer cells. Am J Physiol Gastrointest Liver Physiol 2002, 283:G719-G726.
50. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
51. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009, 1790:682-693.
52. Nemeth E., Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009, 122:78-86.
53. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006, 38:531-539.
54. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004, 36:77-82.
55. Andriopoulos B., Corradini E., Xia Y., Faasse S.A., Chen S., Grgurevic L., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009, 41:482-487.
56. Meynard D., Kautz L., Darnaud V., Canonne-Hergaux F., Coppin H., Roth M.P. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009, 41:478-481.
57. Silvestri L., Pagani A., Nai A., De Domenico I., Kaplan J., Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008, 8:502-511.
58. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113:1271-1276.
59. Wrighting D.M., Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006, 108:3204-3209.
60. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002, 99:4596-4601.
61. Corna G., Campana L., Pignatti E., Castiglioni A., Tagliafico E., Bosurgi L., et al. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 2010, 95:1814-1822.
62. Wang L., Johnson E.E., Shi H.N., Walker W.A., Wessling-Resnick M., Cherayil B.J. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol 2008, 181:2723-2731.
63. Ferris C.D., Jaffrey S.R., Sawa A., Takahashi M., Brady S.D., Barrow R.K., et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999, 1:152-157.
64. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 1997, 94:10919-10924.
65. Cairo G., Recalcati S., Mantovani A., Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol 2011, 32:241-247.
66. Vallelian F., Schaer C.A., Kaempfer T., Gehrig P., Duerst E., Schoedon G., et al. Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood 2011, 116:5347-5356.
67. Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069.
68. Yang J., Moses M.A. Lipocalin 2: a multifaceted modulator of human cancer. Cell Cycle 2009, 8:2347-2352.
69. Bao G., Clifton M., Hoette T.M., Mori K., Deng S.X., Qiu A., et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol 2011, 6:602-609.
70. Yang J., Bielenberg D.R., Rodig S.J., Doiron R., Clifton M.C., Kung A.L., et al. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A 2009, 106:3913-3918.
71. Berger T., Cheung C.C., Elia A.J., Mak T.W. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Proc Natl Acad Sci U S A 2011, 107:2995-3000.
72. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 2009, 33:222-230.
73. Magaro M., Zoli A., Altomonte L., Mirone L., Corvino G., Storti S., et al. Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation. Ann Rheum Dis 1990, 49:268-269.
74. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Iolfsdorf W.J., Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002, 100:3776-3781.
75. Camaschella C., Pagani A. Iron and erythropoiesis: a dual relationship. Int J Hematol 2011, 93:21-26.
76. Nairz M., Sonnweber T., Schroll A., Theurl I., Weiss G. The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect 2012, 14:238-246.
77. Weiss G., Gordeuk V.R. Benefits and risks of iron therapy for chronic anaemias. Eur J Clin Invest 2005, 3:36-45.
78. Kaltwasser J.P., Kessler U., Gottschalk R., Stucki G., Moller B. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001, 28:2430-2436.
79. Weiss G., Meusburger E., Radacher G., Garimorth K., Neyer U., Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int 2003, 64:572-578.